talkright
- Science
The Drug Resurrector
With Big Pharma spending upward of $1 billion to bring a single drug to pharmacy shelves, its little wonder that unprofitable afflictions like malaria and African sleeping sickness go largely ignored. Curtis Chong witnessed this neglect firsthand in 2001 as a third-year medical student working in an emergency room in Mozambique. Day and night, malaria patients lined up for treatment, but Chongs medication stockpile was often too low or too antiquated to treat drug-resistant strains of the disease, and people were dying. Six years later, the 31-year-old pharmacologist is spearheading an innovative way to bring better drugs, and more of them, to the developing world.
5.5.2008 at 09:04pm - Comment by talkrightHomeopathy can be a solution for this problem. As homeopathic system of treatment is symptomatic so medicine is given when symptoms meet.I patient has a symtoms of Malaria he is given the medicine which symptoms are similar to the patients symptoms, by this I mean that the patient is given such medicine which was tested on healthy person and which caused him sypmtoms of Malaria like sincona bark/China off. I am myself a homeopath and I treat 13 different types of patients with Nux Vomica if symptoms meet.And Pulsatilla is useful to treat more than 60 types of ailments if symptoms say so. Homeopathic medicines are tested on human beings No single homeopathic medicine has been rejected for the last 200 years. talkright 04 May 2008 Lets make the world peaceful
Download Our iPhone App
Stay up to date on the latest news of the future of science and technology from your iPhone with full articles, images and offline viewing
Follow Us On Twitter
Featuring every article from the magazine and website, plus links from around the Web. Also see our PopSci DIY feed
Become a Fan On Facebook
Share links with friends, comment on stories and more
December 2009: Best of What's New
In our December issue, Popular Science names the 100 best innovations of the year: bombproof wallpaper, self-parking cars, the fastest helicopter, and 97 more. Plus inventor profiles and videos.
Check out the best of what's new here.
Popular Science Photo Pool
Popular on Popsci
Most Viewed
- IBM's Blue Gene Supercomputer Models a Cat's Entire Brain
- China's Weather Manipulation Brings Crippling Snowstorm to Beijing
- What Would Happen if I Ate a Teaspoonful of White Dwarf Star?
- Kaboom! Blitzer Railgun Completes First Successful Test Firing
- Mesmerizing, Isn't It?
- Intel Wants Brain Implants in Its Customers' Heads by 2020
- Best of What's New 2009: The Year's 100 Greatest Innovations
- Batteryless Remote Control Pulls Power from Your Button Presses
- Video: The View From the Highest Man-Made Point on Earth
- Google's Replacement for HTTP Protocol to Make Web Browsing Twice as Fast
Most Commented
- Guess This Part, Win a Tool
- This Week in the Future, November 6-13, 2009
- This Week in the Future, November 16-20, 2009
- Air Force Seeks Better Space Technology: Are Star Wars Upon Us?
- Kaboom! Blitzer Railgun Completes First Successful Test Firing
- Intel Wants Brain Implants in Its Customers' Heads by 2020
- IBM's Blue Gene Supercomputer Models a Cat's Entire Brain
- China's Weather Manipulation Brings Crippling Snowstorm to Beijing
- What Would Happen if I Ate a Teaspoonful of White Dwarf Star?
- So Much For "Hopenhagen"
Most Emailed
- Gallery: Hoover Dam Bridge
- What Would Happen if I Ate a Teaspoonful of White Dwarf Star?
- Fermi Telescope Detects Antimatter in Lightning Storms
- World's First Osmotic Power Plant Goes Live in Norway
- High-Pressure Diamond Anvil Creates a New Solid from Xenon and Hydrogen
- President Obama Hopes to Jumpstart Science and Technology Education With New Initiative
- New Reactor Uses Sunlight to Turn Water and Carbon Dioxide Into Fuel
- Mourning the Death of the Meta Media Experience
- The (Slightly) Poorer Man's Tesla: ECOS Harbinger
- Decoded Corn Genome Promises Higher Yields, Better Biofuels, New Plastics
Today on PopSci.com
Copyright © 2009 Popular Science
A Bonnier Corporation Company. All rights reserved. Reproduction in whole or in part without permission is prohibited.
